<DOC>
	<DOCNO>NCT01086865</DOCNO>
	<brief_summary>Clinical study phase III , randomize , double-blind , prospective , comparative non-inferiority evaluate efficacy tolerability use APETIVITON BC compare Petivit BC appetite stimulate child , adult elderly .</brief_summary>
	<brief_title>Clinical Study Phase III , Randomized , Double-blind , Prospective Comparative Evaluate Efficacy Tolerability Using APETIVITON BC Compared Petivit BC Appetite Stimulate .</brief_title>
	<detailed_description>Clinical trial phase III , randomize , double-blind , prospective , comparative non-inferiority evaluate efficacy tolerability use APETIVITON BC compare Petivit BC stimulation appetite child , adult elderly . A total 150 patient , distribute follow : 25 patient treated child Apetiviton BC,25 patient treat child Petivit BC , ( 2-6 year ) . 25 adult patient treat Apetiviton BC,25 adult patient treat Petivit BC , ( 18-50 year . 25 elderly patient treat Apetiviton BC,25 elderly patient treat Petivit BC . ( 60-80 year .</detailed_description>
	<criteria>For group : Patients inappetence ; Patients able understand maintain adherence protocol ; Washout 20 day ingestion prior similar drug ; Patients able understand correct use medication ; Patients consent participate study sign inform consent ; Children : Patients ethnic group male female , age 2 6 year ; Adults : Patients ethnic group male female , age 18 50 year ; Female patient childbearing age , sexually active , make pregnancy test result negative , furthermore , use contraceptive method contraception , condom , IUD diaphragm . Elderly : Patients ethnic group male female , age 60 80 year . Female patient childbearing age , sexually active , make pregnancy test result negative , furthermore , use contraceptive method contraception , condom , IUD diaphragm . For group : Patients glaucoma open closure angle ; Patients predisposition urinary retention ; Patients stenous peptic ulcer pylorusduodenal obstruction ; Debilitated patient acute attack asthma ; Alcoholic ; Patients loss appetite cause serious disease ; Patients make use drug central nervous system depressant ; Patients make use medicine monoaminooxidase inhibitor , tricyclic antidepressant , phenothiazine , probenecid , levodopa , phenytoin , phenobarbital , chloramphenicol , cyclophosphamide , cyclosporine , chlorambucil , corticotropin , mercaptopurine , isoniazid , penicillin , estrogens , contraceptive , haloperidol , ipatr√≥pico , barbiturate , primidone , salicylate ; Patients know hypersensitivity component formula ; Patient participate another clinical study ; No able adhere protocol ; Patients pregnant breastfeeding ; Any condition opinion investigator impossible include patient 's adherence protocol .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>inappetence</keyword>
	<keyword>apetiviton BC</keyword>
</DOC>